Winners / 2025

ALZpath pTau217 Antibody

By: ALZpath
Bronze

Master Category:

Award Category: Health, Medical & Biotech

Award Sub-Category: Advancements in Neurological Treatments

ALZpath’s proprietary phosphorylated tau (pTau217) antibody, powers highly sensitive, convenient and scalable blood tests, to detect minute concentrations of pTau217, a hallmark of Alzheimer’s disease, aiding early diagnosis before symptoms appear. This supports early detection, trial initiation and treatment monitoring to improve patient outcomes.

Explore more Health & Wellness

Put your innovation in the spotlight.

For four decades, the Edison Awards have recognized innovative products, services, and technologies that create meaningful value and impact. Explore the categories, find the right fit, and enter your new innovation for recognition.

Ready for Nomination Season?

Complete the form below to download the 2027 Nomination Guide.

A Founders Guide to Modern Innovation
The Future of the Grid – Panel Discussion 2024 Edison Awards
Edison Award-Winning Brain Technology Featured in U.S. News & World Report